Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
CIS Publishes Corrective Action/Preventative Action (CAPA) System White Paper
CIS, a pharmaceutical compliance consulting firm, announced the publication of its white paper on compliance-focused approaches to establishing an efficient, effective and sustainable Corrective Action/Preventative Action (CAPA) system for pharmaceutical manufacturers. - October 21, 2010 - Compliance Implementation Services
Do You Believe in Cool Chain Excellence? IQPC's Cool Chain Europe Excellence Awards Return for 2011
Nominations are currently being accepted for the Cool Chain Europe Excellence Awards 2011. This runs in conjunction with Cool Chain Europe 2011 brought to you by Pharma IQ (a division of IQPC). - October 16, 2010 - IQPC
Rottenstein Law Group Cautions Victims About Marketing Web Sites Offering Free Case Evaluations
The Rottenstein Law Group is warning victims of defective consumer products about Web sites that are not what they appear to be. The firm cautions users who search online for legal consultation that many Web sites designed to suggest affiliation with a law firm are simply commercial sites soliciting personal information that can be sold and permission to send the user marketing emails directly. - October 13, 2010 - The Rottenstein Law Group
Creativ-Ceutical to be Centre Stage at ISPOR Europe 2010
Strengthening its positioning as one of the major pan-European consulting companies in pricing, market access and health economics, Creativ-Ceutical will be present in force at ISPOR 2010 from 6-9 November in Prague. - October 13, 2010 - Creativ-Ceutical
Peterson & Associates, P.C. is Committed to Helping Patients of Meridia®
Peterson & Associates, P.C. is committed to representing patients of Meridia® that have been a victim of Meridia®. Meridia® , the obesity drug, has been withdrawn due to a potential increased risk of heart attack or stroke, as requested by the FDA. - October 10, 2010 - Peterson & Associates, P.C.
Senior Formulations Scientist at Metrics Earns CPIP Credential
Joseph E. “Joe” Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional™ (CPIP™) credential. Awarded by the ISPE Professional Certification Commission, the CPIP credential is the only... - October 09, 2010 - Metrics, Inc.
MedPro Rx, Inc. Listed Among Best Places to Work by Triangle Business Journal
Local Specialty Infusion Pharmacy Places in Top Three for Small Businesses Category - October 07, 2010 - MedPro Rx, Inc.
Production and Market of Polyvinyl Pyrrolidone in China Now Available at ReportsandReports
With increasing demand from downstream industries and support from Chinese government, PVP production and consumption has been growing rapidly in the past few years, and China has become one of most important PVP producers in the world with larger export volume. - October 07, 2010 - marketsandmarkets
Health Decisions CEO to Address Adaptive Patient Enrollment at Achieving Operational Efficiency in Clinical Trials 2010
Dr. Michael Rosenberg will discuss how continuously adapting enrollment during studies prevents delays and setbacks. - October 03, 2010 - Health Decisions
Pharmaceutical Markets in Latin America Reached $50 Billion in Sales
This report covers eight pharmaceutical markets in Latin America including Venezuela, Chile, Brazil, Mexico, Argentina, Colombia, Cuba, and Peru. - October 01, 2010 - MarketResearch.com
New Avandia® Restrictions in the US | Peterson & Assoc., P.C. is Committed to Inform Patients at New Website
Peterson & Assoc., P.C. is providing the latest information for Victims about New Avandia® Restrictions at New Website, www.avandiaheartdamage.com - September 27, 2010 - Peterson & Associates, P.C.
New Companion Diagnostics Require Pharma Strategy Changes, Scientia Advisors Say
For pharma companies with blockbusters already on the market, the new diagnostic tools of personalized medicine, also known as “theranostics,” can lead to a sales decline—a possibility that should “keep drug executives up at night” developing new strategies to maintain their profit margins. - September 25, 2010 - HarrisComGroup/Scientia Advisors
PharmaZell Continues Expansion of Pharmaceutical Manufacturing Capacity in India
PharmaZell GmbH, a European Contract Manufacturing Organization for active pharmaceutical ingredients and advanced intermediates, has once again expanded its manufacturing capabilities in India. In 2010, PharmaZell completed construction of a cGMP Kilo-lab at its R&D center in Vizag, India. - September 21, 2010 - PharmaZell
Synowledge to Participate in Pacific Drug Safety Summit
Synowledge LLC announced today that Dr. Jacinta Aniagolu Johnson, Director, Pharmacovigilance and Risk Management, will be representing Synowledge at Pacific Drug Safety Summit at San Francisco Airport Marriott, Burlingame, California, USA on 23rd-24th September 2010. - September 18, 2010 - Synowledge
Synowledge Continues Global Expansion with New Offices in UK and USA
Synowledge LLC, the market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations announced its inauguration of two new offices in Brentford, UK and Columbus OH, USA as part of its ongoing global growth strategy. These two new offices will act... - September 16, 2010 - Synowledge
Synowledge Announces 15 New Customer Wins Worldwide
Synowledge LLC, a market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations of all sizes announced its largest customer win growth to-date. Synowledge signs 15 new customers in 2010 (including a fortune 100 company and a top 20 pharma... - September 10, 2010 - Synowledge
Despite Economic Turmoil, CIS Named to Inc. 5000 List of Fastest-Growing Private Companies in America
Compliance Implementation Services (CIS) announced today that it has been named to Inc. Magazine’s fourth annual Top 5000 list of fastest-growing privately held companies in the United States. - September 09, 2010 - Compliance Implementation Services
GenScript Launches CloneReadyTM Gene Collections
GenScript’s CloneReadyTM Gene Collections provide convenient and cost-effective solutions to researchers’ gene related practices. - September 09, 2010 - GenScript USA Inc.
Newly Developed Cancer Treatments to Generate $25 Billion by 2015 According to Report Posted on MarketReseach.com
This report concentrates on the pharmaceutical and biopharmaceutical market, including biotechnology drug development, orphan drugs, fast track drug status, other accelerated methods for drug approval, pharmaceutical regulatory exclusivity, pediatric expansions, and biosimilars. - September 03, 2010 - MarketResearch.com
Bio-Med QC Offers an Indiana Pharmacy Exclusive
Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC
P.A.N.D.O.R.A. Urges Swift Action by U.S. Health Agencies to Improve Quality of Life for CFS Patients
Patients with chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) in other countries, have endured too many years of misinformation, neglect, and mistreatment. “With a retrovirus infection now demonstrated to be present in the majority of CFS patients, now is the time... - August 25, 2010 - PANDORA Org
Nutricap Labs Named to 2010 Inc. 500 | 5,000 List, Recognized as One of America’s Fastest Growing Private Companies for a Second Consecutive Year
Nutricap Labs today announced its placement on the 2010 Inc. 500 | 5,000 list. The annual list, compiled by Inc. Magazine, ranks the 5,000 fastest-growing, privately held companies in America based on criteria such as gross dollars of growth, revenue, metro region and industry over a four-year period. - August 25, 2010 - Nutricap Labs
Indian IVD Market to Grow 15% Through 2014
This report on the market for clinical in vitro diagnostic (IVD) tests in India, covers both reagent and instrumentation markets. The report also provides an overview of the Indian economy as a whole and the structure of the healthcare system in particular. - August 25, 2010 - MarketResearch.com
ChemImage Reaches Agreement with Light Ace HK LTD to Distribute the Falcon II System and Services in China
ChemImage Corporation recently reached an agreement with Light Ace HK LTD, a China-based distributor of laboratory equipment, instrumentation and services, to offer the Falcon II Wide-Field Raman Chemical Imaging System and select analytical contract services in China. “This agreement... - August 25, 2010 - ChemImage Corporation
Nutricap Labs President Recognized by Long Island Business News as One of the Area’s Top Business Professionals
President of leading vitamin and supplement manufacturer named to Long Island Business News’ Fifty or so Around 50 Class of 2010 for his leadership, business acumen and philanthropic efforts. - August 23, 2010 - Nutricap Labs
CHI’s BioPharma Strategy Series Presents the Inaugural Mitigating Safety Risks in Early Clinical Development Executive Forum November 8-9, 2010, Philadelphia, PA
Presentations Discuss Bridging the Gap Between Pre-Clinical and Clinical Safety to Improve Prediction. - August 20, 2010 - Cambridge Healthtech Institute
Pharma Industry Veteran to Address Recent Changes to FDA/GCP Requirements at Quality System Event
Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Dr. Annette Horner, Ph.D., Senior Director of Clinical Compliance Services for CIS, will be speaking at the “Effective R&D SOPs, Process Maps, and the Quality System” event on... - August 19, 2010 - Compliance Implementation Services
Sysmex, Beckman Both Seeking Top Spot in Hematology IVD Market
This report reviews the key products dominating the Hematology IVD Market segment, the innovations that are occurring, and trends that are impacting the segment. - August 14, 2010 - MarketResearch.com
Clinical Trials in Russia. 2nd Quarter 2010.
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 178 new clinical trials of all types including local and bioequivalence studies during the second quarter of 2010 demonstrating a 38% increase over the corresponding period of last year. - August 14, 2010 - Synergy Research Group
Japan to Become Key Grow Region of the Insomnia Market Over the Next 10 Years
This report quantifies the current and future size of the insomnia market in the seven major pharmaceutical markets. - August 13, 2010 - MarketResearch.com
Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt by Datamonitor Now Available at ReportsandReports
The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market. - August 13, 2010 - ReportsandReports
AdvantaPure(R)’s BioPharm Tubing & Single Use Systems to be Featured at Upcoming Fall Shows
AdvantaPure will exhibit its high purity pharmaceutical and biopharmaceutical products at three industry trade shows this fall. AdvantaFlex(R) biopharm tubing and molded, Class VI silicone, single use systems will be the focus. Other items include silicone container closures and manifold identification solutions. - August 12, 2010 - NewAge Industries, Inc.
Increasingly, Pharma Sold Over the Counter in Developing Nations
The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. - August 06, 2010 - MarketResearch.com
Growth in IVD Testing Despite Economic Jitters, Says Report
Market size, forecasts, and shares are provided; and discussion of regional numbers of each segment is provided where possible. - August 01, 2010 - MarketResearch.com
Major Pharmaceuticals Announces Retirement and Transition Plan for Michael Redd
Major Pharmaceuticals a leading national supplier of generic over the counter pharmaceuticals today announced that Michael Redd will step down as President on August 7, 2010 for personal reasons. Redd will be succeeded by Thomas Larkin, formerly Chief Strategic Officer of The Harvard Drug Group,... - July 31, 2010 - Major Pharmaceuticals
Doctors.net.uk Strengthens Pharmaceutical Team
New hires are set to support strong business growth at Doctors.net.uk during first half of 2010. - July 31, 2010 - Doctors.net.uk
Biotage Introduces SLE+ High-Performance Supported Liquid Extraction Sample Preparation Columns
Biotage (STO: BIOT), a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry... - July 29, 2010 - Biotage
Biotage Introduces Highly-Selective AFFINILUTE MIP
Biotage announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation. Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and lower cost sample preparation. - July 29, 2010 - Biotage
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
CIS Expands Its Business Development Force with Key New-Hire
CIS is pleased to announce that it is expanding its business development staff with the addition of industry veteran Joe Cunningham. - July 16, 2010 - Compliance Implementation Services
New Report Top 10 Drug Delivery Technologies (2010 - 2015) Published by MarketsandMarkets
More than 25% of the marketed drugs fail to provide expected commercial returns due to drug distribution and absorption levels within the body (pharmacokinetics) therefore signifying the importance of drug delivery systems. - July 15, 2010 - marketsandmarkets
InnoCore and Nanomi Strengthen Collaboration in Microsphere Technology for Peptide and Protein Delivery
InnoCore Technologies BV and Nanomi BV announce a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations for the sustained delivery of biotherapeutics. - July 14, 2010 - Nanomi
UltraTek Automatic Pill Reminder(APR) Cures Common “Medication Forgetfulness”
UltraTek, a technology research and product development company, is pleased to announce that their new Automatic Pill Reminder (APR) is available for administration of medicine to patients (or pets). “Unlike conventional pill reminder products,” said Douglas Walker, VP of Marketing... - July 14, 2010 - UltraTek
European Pharma Leader STADA Arzneimittel AG Praises eluzzion CRM
CEO of STADA Czech Republic Writes in Official Letter of Reference: "I can confidently recommend eluzzion CRM to any company looking for a thorough, dynamic software solution to support their sales force and improve their performance levels." - July 11, 2010 - Data System Solutions s.r.o.
Chinese Pharma Powers on Despite Global Economic Slowdown
According to China Pharmaceutical Guide 2010 (5th Edition), which was officially released in July 2010 by WiCON International Group LLC (publisher of Pharma China), the Chinese pharmaceutical sector maintained its high growth trend in 2009 despite the global financial crisis and economic slowdown. - July 09, 2010 - WiCON International Group LLC
Leading Regulatory Bodies, Pharmaceutical and Biotech Companies Including MHRA, FAGGS and BfArM to Address the Challenges Facing Today's Phase I Trials
Pharma IQ is pleased to announce the dates for the Innovation in Phase I Clinical Development conference taking place on 21st and 22nd September 2010. - July 09, 2010 - IQPC
Compliance and Ethics Attorney Complements CIS Service Offerings
Compliance Implementation Services (CIS) announced today that Jamie L. Ghen, Esquire, has joined the firm as Director of Compliance, Ethics and Legal Affairs. - July 08, 2010 - Compliance Implementation Services
Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016 Now Available at ReportsandReports
GlobalData’s report, “Pulmonary Arterial Hypertension (PAH) – Pipeline Assessment and Market Forecasts to 2016” provides an essential source of information and analysis on the global PAH market. The report identifies the key trends shaping and driving the global PAH market. - June 26, 2010 - ReportsandReports
Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016 Now Available at ReportsandReports
GlobalData, the industry analysis specialist, has released a new report, “Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016.” The report is an essential source of information and analysis on the global dyslipidemia market. The report identifies the key trends shaping and driving the global dyslipidemia market. - June 26, 2010 - ReportsandReports
Nutricap Labs Wins Stevie® Award in 8th Annual American Business Awards
New York-based vitamin and supplement manufacturing company named 2010’s Best Overall Company of the Year by American Business Awards during ceremony at Marriott Marquis Hotel in New York City. - June 23, 2010 - Nutricap Labs